☆ 4.4 Letter

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

HEMATOLOGICAL ONCOLOGY (2017)

Get Full Text
Add to Collection

Journal

HEMATOLOGICAL ONCOLOGY
Volume 35, Issue 4, Pages 914-917

Publisher

WILEY
DOI: 10.1002/hon.2320

Keywords

-

Categories

Oncology Hematology

Funding

  1. Celgene Corporation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.